Data through close

Modeled dealer-delta extremes

Where was modeled dealer delta most positive or negative on Oct 16, 2026?

The dashboard convention assumes dealers hold the opposite side of listed option-holder delta, normalized by total open interest. It is a scenario model, not observed dealer inventory. Data through close. Descriptive only, not a recommendation.

At a glance

50 tickers qualified. First five: ARDX (0.430), UAA (0.308), KKR (0.257), ABR (0.257), BX (0.226).

Modeled dealer-delta extremes as of Oct 16, 2026 close
# Ticker Close Open interest Normalized dealer delta
1 ARDX 3.09 201,015 0.430
2 UAA 4.74 497,093 0.308
3 KKR 86.21 258,084 0.257
4 ABR 2.69 165,220 0.257
5 BX 106.63 456,854 0.226
6 OWL 8.85 727,148 0.194
7 COHR 232.90 257,074 0.183
8 HYG 76.86 9,306,382 0.178
9 CCJ 81.52 397,150 0.175
10 KORU 10.64 354,756 0.169
11 GT 4.29 169,052 0.168
12 CBRS 127.21 247,678 0.167
13 RUT 2,721.37 707,213 0.161
14 SOXX 493.39 496,974 0.159
15 NLY 18.23 164,006 0.154
16 AGNC 8.72 693,210 0.148
17 IWM 270.44 9,513,883 0.147
18 APO 110.78 330,276 0.146
19 ASHR 31.12 362,303 0.146
20 SKHY 136.49 982,154 0.139
21 KBE 63.62 215,700 0.136
22 LCID 3.13 835,064 0.136
23 SMH 539.79 1,492,950 0.129
24 XLI 167.76 504,946 0.128
25 XEL 76.31 202,480 0.126
26 CHGG 0.73 127,423 -0.498
27 INO 0.99 108,250 -0.490
28 EH 3.61 234,144 -0.486
29 XP 29.23 1,197,182 -0.461
30 BNO 67.19 196,348 -0.432
31 LAES 1.79 836,814 -0.430
32 CWH 4.51 106,849 -0.424
33 CNC 69.16 207,182 -0.420
34 REI 1.37 135,433 -0.415
35 CAN 0.23 148,437 -0.415
36 CODI 10.01 258,567 -0.404
37 HLF 14.60 135,727 -0.395
38 ALT 2.20 178,695 -0.394
39 PAA 25.25 232,633 -0.391
40 SG 10.04 244,243 -0.389
41 NAK 0.89 224,653 -0.388
42 PACB 1.73 175,075 -0.379
43 BTG 5.31 527,383 -0.371
44 ETSY 85.14 155,185 -0.363
45 IOVA 13.62 407,481 -0.355
46 ASPI 2.14 145,860 -0.351
47 DLO 14.67 227,726 -0.351
48 IBRX 9.18 633,602 -0.348
49 PBR 26.00 2,137,541 -0.343
50 GENI 6.35 121,032 -0.339

Screens describe what the data shows after the close. They are not trade recommendations; see the disclaimer and the methodology.